Revenue (Quarterly) Chart

View Revenue (Quarterly) for PAIOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
December 31, 2015 0.0297M
September 30, 2015 0.0059M
June 30, 2015 0.0067M
March 31, 2015 0.0372M
December 31, 2014 1.959M
September 30, 2014 0.4854M
June 30, 2014 2.081M
March 31, 2014 0.0051M
December 31, 2013 3.682M
September 30, 2013 0.3973M
June 30, 2013 0.0064M
March 31, 2013 1.607M
December 31, 2012 3.059M
September 30, 2012 2.063M
June 30, 2012 0.0119M
March 31, 2012 29.88M
December 31, 2011 0.2459M
September 30, 2011 0.3429M
June 30, 2011 3.532M
March 31, 2011 0.5046M
December 31, 2010 2.537M
September 30, 2010 0.476M
June 30, 2010 1.896M
March 31, 2010 1.025M
Date Value
December 31, 2009 0.5449M
September 30, 2009 0.5384M
June 30, 2009 0.521M
March 31, 2009 0.5273M
December 31, 2008 0.618M
September 30, 2008 0.7252M
June 30, 2008 0.8786M
March 31, 2008 2.473M
December 31, 2007 0.6023M
September 30, 2007 2.947M
June 30, 2007 1.336M
March 31, 2007 1.696M
December 31, 2006 3.086M
September 30, 2006 6.622M
June 30, 2006 1.901M
March 31, 2006 1.632M
December 31, 2005 0.9538M
September 30, 2005 21.09M
June 30, 2005 0.4249M
March 31, 2005 0.4757M
December 31, 2004 0.458M
September 30, 2004 0.3701M
June 30, 2004 19.63M
March 31, 2004 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
CureVac NV 63.26M
Anbio Biotechnology --
Epigenomics AG --
ACADIA Pharmaceuticals, Inc. 307.96M
Alkermes Plc 496.01M